A single nucleotide polymorphism in CHAT influences response to acetylcholinesterase inhibitors in Alzheimer's disease

Pharmacogenetics and Genomics

Volumn 16, Issue 2, 2006, Pages 75-77

  Harold, Denise ^a   MacGregor, Stuart ^a   Patterson, Cathryn E ^b   Hollingworth, Paul ^a   Moore, Pamela ^a   Owen, Michael J ^a   Williams, Julie ^a   O'Donovan, Michael ^a   Passmore, Peter ^b   McIlroy, Stephen ^b   Jones, Lesley ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Acetylcholinesterase inhibitors; Alzheimer's disease; Choline acetyltransferase; Pharmacogenetics

Indexed keywords

CHOLINE ACETYLTRANSFERASE; CHOLINESTERASE INHIBITOR;

AGED; ALZHEIMER DISEASE; ARTICLE; CATALYSIS; CHOLINERGIC SYSTEM; COGNITION; FEMALE; GENE SEQUENCE; GENETIC CODE; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; PREDICTION; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 31344460780     PISSN: 17446872     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fpc.0000189799.88596.04     Document Type: Article

References (16)

1. Bowen DM, Smith CB, White P, Davison AN. Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies. Brain 1976; 99:459-496.
2. Davies P, Maloney AJ. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 1976; 2:1403.
3. Perry EK, Perry RH, Blessed G, Tomlinson BE. Necropsy evidence of central cholinergic deficits in senile dementia. Lancet 1977; 1:189.
4. Perry EK, Perry RH, Blessed G, Tomlinson BE. Changes in brain cholinesterases in senile dementia of Alzheimer type. Neuropathol Appl Neurobiol 1978; 4:273-277.
5. Davies P. Neurotransmitter-related enzymes in senile dementia of the Alzheimer type. Brain Res 1979; 171:319-327.
6. Wilcock GK, Esiri MM, Bowen DM, Smith CC. Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities. J Neurol Sci 1982; 57:407-417.
7. Erickson J, Varoqui H, Schafer M, Mod W, Diebler M, Weihe E, et al. Functional identification of a vesicular acetylcholine transporter and its expression from a 'cholinergic' gene locus. J Biol Chem 1994; 269:21929-21932.
8. Nordberg A, Svensson AL. Cholinesterase inhibitors in the treatment of Alzheimer's disease: a comparison of tolerability and pharmacology. Drug Saf 1998; 19:465-480.
9. Harold D, Peirce T, Moskvina V, Myers A, Jones S, Hollingworth P, et al. Sequence variation in the CHAT locus shows no association with late-onset Alzheimer's disease. Human Genetics 2003; 113:258-267.
10. Cook LJ, Ho LW, Wang L, Terrenoire E, Brayne C, Evans JG, et al. Candidate gene association studies of genes involved in neuronal cholinergic transmission in Alzheimer's disease suggests choline acetyltransferase as a candidate deserving further study. Am J Med Genet B Neuropsychiatr Genet 2005; 132:5-8.
11. Abecasis GR, Cardon LR, Cookson WO. A general test of association for quantitative traits in nuclear families. Am J Hum Genet 2000; 66:279-292.
12. Dudbridge F. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 2003; 25:115-121.
13. Lynch M, Walsh B. Genetics and Analysis of Quantitative Traits. Sunderland, MA, Sinauer Associates, 1998.
14. Purcell S, Cherny SS, Sham PC. Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003; 19:149-150.
15. Suh G-H, Ju Y-S, Yeon BK, Shah A. A longitudinal study of Alzheimer's disease: rates of cognitive and functional decline. Int J Geriatr Psychiatry 2004; 19:817-824.
16. McCarten JR, Rottunda SJ, Kuskowski MA. Change in the mini-mental state exam in Alzheimer's disease over 2 years: the experience of a dementia clinic. J Alzheimers Dis 2004; 6:11-15.